ATON PORTAGE BIOTECH INC.

Nasdaq portagebiotech.com


$ 5.46 $ -0.07 (-1.34 %)    

Tuesday, 28-Oct-2025 19:56:40 EDT
QQQ $ 633.55 $ 4.83 (0.77 %)
DIA $ 476.83 $ 1.80 (0.38 %)
SPY $ 687.33 $ 1.82 (0.27 %)
TLT $ 92.10 $ 0.24 (0.26 %)
GLD $ 364.95 $ -2.63 (-0.72 %)
$ 5.16
$ 5.15
$ 5.08 x 40
$ 5.51 x 200
$ 5.02 - $ 5.45
$ 2.95 - $ 15.82
273,167
na
11.76M
$ 1.10
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

AlphaTON Capital Corp (Nasdaq: ATON) and its wholly owned oncology-focused subsidiary Tarus Therapeutics, LLC, operating as Cyn...

Core News & Articles

Telegram's more than 1 billion monthly active users represent the world's largest untapped market for AI agents that ac...

 alphaton-shares-are-soaring-wednesday-whats-going-on

AlphaTON Capital Corp. (NASDAQ:ATON) shares are trading higher Wednesday after the company announced a letter of intent to eval...

 whats-behind-alphaton-capitals-123-after-hours-spike

AlphaTON Capital Corp (NASDAQ:ATON) shares surged in after-hours trading on Tuesday, jumping 123.12% from the regular session c...

Core News & Articles

Under the terms of the LOI, AlphaTON Capital intends to acquire a 51% equity interest in GAMEE and 51% of the GAMEE (GMEE) and ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION